Industry: Medical Aesthetics Region: United States Transaction Price: USD 1 million Transaction Method: Equity Financing
Company Profile:
The company is a developer, manufacturer and marketer of silicone mark management products, headquartered in Illinois, USA. Its products are used for scar treatment and can be used as a gel for self-adhesion to reduce or prevent scars caused by trauma or surgery. The products are approved by the US FDA, bear the CE mark, and use medical-grade silicone purchased in the United States. Production. The company is now seeking to increase overseas distributors to expand the brand's international influence.
Cooperation intention
At present, the company is looking for Chinese partners, and hopes to cooperate with powerful domestic distributors to obtain OTC (over the counter) in pharmacies, health products stores, hypermarkets and/or online to arrange product display and sales, and jointly develop the Chinese market.